Adamson H G. Society intelligence: the dermatological society of London[J]. Br J Dermatol, 1905, 17:222.
[2]
Cheon E, Yang S, Han J H,et al. Systemic juvenile xanthogranuloma involving the bone marrow, multiple bones, and the skin that developed during treatment of acute lymphoblastic leukemia in remission state[J]. Pediatr Dev Pathol, 2018, 21(5): 489-493.
Dehner L P. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneousmanifestations[J]. Am J Surg Pathol, 2003, 27(5):579-593.
Pirillo V,Prontera A, Rizzo P,et al. A rare case of intramedullary solitary juvenile xanthogranuloma of the lumbar spine in the adult: a case report[J]. J Spine Surg, 2017, 3(3): 504-508.
Fölster H R. Severe systemic juvenile xanthogranuloma is an indication for systemictherapy[J]. Br J Dermatol, 2017, 176(2): 302-304.
[10]
Kuruvilla R,Escaravage G K , Finn A J, et al. Infiltrative subcutaneous juvenile xanthogranuloma of the eyelid in a neonate[J]. Adv Ophthalmic Plast Reconstr Surg, 2009, 25(4):330-332.
[11]
Liu D T, Choi P C, Chan A Y. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologicstudy of 129 patients from the Kiel pediatric tumor registry[J]. Am J Surg Pathol, 2005, 29(8): 1117-1118.
[12]
Bains A, Parham D M. Langerhans cell histiocytosis preceding the development of juvenile xanthogranuloma:a case and review of recentdevelopments[J]. Pediatr Dev Pathol, 2011, 14(6): 480-484.
Ruby K N, Deng A C, Zhang J, et al. Emperipolesis and S100 expression may be seen in cutaneous xanthogranulomas: a multi-institutional observation[J]. J Cutan Pathol, 2018, 45(3): 667-673.
Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry[J]. Am J Surg Pathol,2005, 29(1): 21-28.
2020, Vol. 31 
